The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff.
The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff (TGW). A minimum of 100 patients will be recruited and evenly distributed to two treatment arms. 1st arm: dermal (non-scrotal) application of TGW. 2nd arm: scrotal application of TGW.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
University Clinic Charité, Division of Urology
Berlin, Germany
Franziskus-Hospital, Division of Urology
Bielefeld, Germany
testosterone levels
hormones
sexual function and mood disorder (questionnaire)
compliance (drug accountability)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University Clinic Bonn, Division of Dermatology
Bonn, Germany
Medical University Clinic II, Division of Internal Medicine/Andrology
Cologne, Germany
University Clinic Essen, Division of Internal Medicine
Essen, Germany
J.-W. Goethe University, Medical Clinic I, Division of Internal Medicine
Frankfurt, Germany
University Clinic Giessen, Division of Dermatology/Andrology
Giessen, Germany
University Clinic Halle Wittenberg, Division of Urology/Andrology
Halle, Germany
Endokrinologikum Hamburg
Hamburg, Germany
University Medical Clinic Hannover
Hanover, Germany
...and 5 more locations